Stress Cardiac Magnetic Resonance of Asymptomatic Type 2 Diabetics with Cardiovascular High Risk to Measure Empagliflozin Impact on Myocardial Blood Flow (CATCH-EM)
Clinical trial NCT04541797 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04541797
- Sponsor
- The University of Hong Kong
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2020-10-01
- Primary completion
- 2024-05-08
- Enrollment
- 160
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.